Xifaxan 550 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F8D8S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,802
Award facts
- Contract value 100% obligated
- $24,802.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) with a ceiling value of $24,802.35. This firm fixed-price contract, with an ultimate completion date of December 2, 2025, represents a non-competitive set-aside delivery order issued under the company's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems through its comprehensive pharmaceutical supply chain capabilities.
This delivery order falls under AmerisourceBergen's SPE2DX Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The contract supports customers including the Defense Health Agency and the U.S. Coast Guard, positioning AmerisourceBergen as a key provider within the Department of Defense's pharmaceutical supply infrastructure.
Quick answers
Who was awarded contract SPE2DR26F8D8S?
SPE2DR26F8D8S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26F8D8S worth?
The government has obligated $24,802 on SPE2DR26F8D8S.
Is contract SPE2DR26F8D8S an order under another contract?
Yes. SPE2DR26F8D8S is a delivery order under SPE2DR25D3202, an indefinite delivery contract.
Was contract SPE2DR26F8D8S competed?
The extent of competition for SPE2DR26F8D8S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award